Anonymous: "DSM Press Release", , 30 October 2013 (2013-10-30), pages 1-2, XP055296104, Retrieved from the Internet: URL:https://www.dsm.com/content/dam/dsm/cw orld/en_US/documents/2013-10-30-dsm-and-op thea-sign-agreement-to-manufacture-optheas -lead-product-for-eye-disease.pdf [retrieved on 2016-08-17] (B1)

Anonymous: "VEGF-C Shown to Have Major Role in Age-Related Macular Degeneration (AMD)<CIR.AX> | Reuters", , 8 May 2013 (2013-05-08), XP055140164, Retrieved from the Internet: URL:http://www.reuters.com/article/2013/05 /08/idUSnGNX1QLlf7+1d8+GNW20130508 [retrieved on 2014-09-15] (B1)

DAVYDOVA, N. ET AL.: 'Preparation of human vascular endothelial growth factor-D for structural and preclinical therapeutic studies' PROTEIN EXPRESSION AND PURIFICATION vol. 82, 01 January 2012, pages 232 - 239, XP028457992 DOI: 10.1016/J.PEP.2012.01.001 (B1)

WO-A2-2005/087808 (B1)

MARKOWSKA, A. I. ET AL.: 'Galectin-3 Protein Modulates Cell Surface Expression and Activation of Vascular Endothelial Growth Factor Receptor 2 in Human Endothelial Cells' THE JOURNAL OF BIOLOGICAL CHEMISTRY vol. 286, no. 34, 26 August 2011, pages 29913 - 29921, XP055220784 DOI: 10.1074/JBC.M111.226423 (B1)

US-A1- 2006 110 364 (B1)

WO-A1-2014/182635 (B1)

MAEKINEN T ET AL: "INHIBITION OF LYMPHANGIOGENESIS WITH RESULTING LYMPHEDEMA IN TRANSGENIC MICE EXPRESSING SOLUBLE VEGF RECEPTOR-3", NATURE MEDICINE, NATURE PUBLISHING GROUP, NEW YORK, NY, US, vol. 7, no. 2, 1 February 2001 (2001-02-01), pages 199-205, XP000990590, ISSN: 1078-8956, DOI: 10.1038/84651 (B1)